Open platform leverage THINK Surgical markets open platform orthopedic robots that support implants from multiple manufacturers, presenting a sales opportunity to expand integration partnerships with additional implant brands and distributors to broaden the addressable market.

Strategic partnerships Recent collaborations with Medacta and Zimmer Biomet suggest a proven path for co-marketing and distribution; prioritize outreach to other major knee and hip implant manufacturers to accelerate channel expansion.

Executive leadership growth New appointments of a Chief Legal Officer and a President/CEO in 2025 indicate a period of strategic scaling and governance maturation; target enterprise-level conversations around regulatory compliance, international expansion, and large-scale capital investments.

Knee and hip focus Core product initiatives such as the TMINI and MOBIO Total Knee System highlight a concentration on knee and hip applications; explore cross-sell opportunities with surgeons and hospitals pursuing advanced robotic-assisted joint replacements.

Mid-market growth potential With a revenue range of 25-50 million and a mid-sized employee base, there is a ripe opportunity to target regional health systems and ambulatory surgery centers looking to upgrade to robotic platforms through favorable pricing, service packages, and training programs.